Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.29 USD | -2.64% | -14.00% | +27.72% |
03:52pm | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.72% | 81.64M | |
+6.77% | 111B | |
+11.05% | 106B | |
-12.87% | 22.24B | |
+0.49% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-10.18% | 16.81B | |
+38.73% | 12.54B | |
-24.61% | 8.09B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Wedbush Trims Passage Bio's Price Target to $5 From $6, Keeps Outperform Rating